Who Paid My Doc Search
Menu
Product Program year 2019 Source: CMS Open Payments

Flublok Quadrivalent

Drug Vaccines

NDC 49281-719-10

Open in the dashboard

General payments

$439,290

9,923 payments

Research payments

$25,037,249

2 payments

Through program year 2019, $439,290 in general payments and $25,037,249 in research payments were reported against Flublok Quadrivalent (Vaccines).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $439,290 9,923
2019 Research $25,037,249 2

Breakdown

Who paid General payments · program year 2019
  1. Sanofi Pasteur Inc. $437,900 9,911 payments
  2. Sanofi-Aventis U.S. LLC $1,377 11 payments
  3. Vaxserve Inc. $14 1 payment
Top recipients General payments · program year 2019
  1. Peter Sebeny Infectious Disease · Newburyport, MA $32,737 7% · 30 payments
  2. Christopher Belcher Pediatric Infectious Diseases · Carmel, IN $32,710 7% · 68 payments
  3. Robert Belshe Infectious Disease · Saint Louis, MO $30,101 7% · 35 payments
  4. Marvin Bittner Infectious Disease · Omaha, NE $21,159 5% · 38 payments
  5. Mohammad Madjid Interventional Cardiology · Ventura, CA $20,399 5% · 10 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Family Medicine $145,137 33% · 4,008 practitioners
  2. Infectious Disease Internal Medicine $122,785 28% · 61 practitioners
  3. Internal Medicine $71,209 16% · 2,570 practitioners
  4. Pediatric Infectious Diseases Pediatrics $40,173 9% · 2 practitioners
  5. Interventional Cardiology Internal Medicine $20,620 5% · 12 practitioners

The top 5 of 94 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Indiana $52,527 12% · 236 recipients
  2. California $51,065 12% · 1,040 recipients
  3. Texas $48,327 11% · 663 recipients
  4. Missouri $34,456 8% · 247 recipients
  5. New Hampshire $33,357 8% · 29 recipients

The top 5 of 52 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

9,923 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record